label: Oncology (pancreatic cancer), multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9, serum, diagnostic algorithm reported qualitatively as positive, negative, or borderline
label_lc: oncology (pancreatic cancer), multiplex immunoassay of c5, c4, cystatin c, factor b, osteoprotegerin (opg), gelsolin, igfbp3, ca125 and multiplex electrochemiluminescent immunoassay (eclia) for ca19-9, serum, diagnostic algorithm reported qualitatively as positive, negative, or borderline